BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 28 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $614,000 | -74.5% | 14,000 | -64.6% | 0.01% | -73.1% |
| Q4 2021 | $2,404,000 | +381.8% | 39,500 | +229.2% | 0.03% | +420.0% |
| Q3 2021 | $499,000 | +37.1% | 12,000 | 0.0% | 0.01% | +66.7% |
| Q2 2021 | $364,000 | +1.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $358,000 | +66.5% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $215,000 | -6.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $229,000 | +16.2% | 12,000 | -4.0% | 0.00% | -25.0% |
| Q2 2020 | $197,000 | +15.2% | 12,500 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $171,000 | -65.5% | 12,500 | -76.2% | 0.00% | -62.5% |
| Q4 2019 | $496,000 | -24.5% | 52,587 | -8.8% | 0.01% | -20.0% |
| Q3 2019 | $657,000 | +2.3% | 57,687 | -9.6% | 0.01% | +42.9% |
| Q2 2019 | $642,000 | – | 63,822 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |